Shenzhen Mindray Bio-Medical Electronics Co., Ltd. (SHE: 300760)
China
· Delayed Price · Currency is CNY 284.44
-13.58 (-4.56%)
Oct 11, 2024, 3:04 PM CST
Shenzhen Mindray Bio-Medical Electronics Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | 2018 - 2014 |
|---|---|---|---|---|---|---|---|
Period Ending | Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 | 2018 - 2014 |
| Operating Revenue | 36,913 | 34,875 | 30,354 | 25,258 | 20,981 | 16,520 | Upgrade
|
| Other Revenue | 74 | 56.61 | 11.83 | 11.73 | 44.89 | 36.43 | Upgrade
|
| Revenue | 36,987 | 34,932 | 30,366 | 25,270 | 21,026 | 16,556 | Upgrade
|
| Revenue Growth (YoY) | 10.45% | 15.04% | 20.17% | 20.18% | 27.00% | 20.38% | Upgrade
|
| Cost of Revenue | 12,662 | 12,075 | 10,956 | 8,967 | 7,459 | 5,799 | Upgrade
|
| Gross Profit | 24,325 | 22,857 | 19,410 | 16,303 | 13,566 | 10,757 | Upgrade
|
| Selling, General & Admin | 7,354 | 7,227 | 6,122 | 5,105 | 4,509 | 4,371 | Upgrade
|
| Research & Development | 3,357 | 3,433 | 2,923 | 2,524 | 1,869 | 1,466 | Upgrade
|
| Other Operating Expenses | -289.56 | -308.79 | -80.36 | -83.14 | -100.81 | -81.83 | Upgrade
|
| Operating Expenses | 10,743 | 10,595 | 9,001 | 7,539 | 6,307 | 5,763 | Upgrade
|
| Operating Income | 13,582 | 12,261 | 10,409 | 8,764 | 7,259 | 4,994 | Upgrade
|
| Interest Expense | -16.58 | -13 | -10.69 | -8.63 | - | - | Upgrade
|
| Interest & Investment Income | 909.23 | 821.64 | 357.91 | 408.14 | 385.7 | 331.3 | Upgrade
|
| Earnings From Equity Investments | - | - | - | - | -4.47 | - | Upgrade
|
| Currency Exchange Gain (Loss) | -168.52 | 119.17 | 171.96 | -227.66 | -253.4 | 156.26 | Upgrade
|
| Other Non Operating Income (Expenses) | -65.66 | -72.51 | -67.82 | -85.92 | -70.86 | -79.67 | Upgrade
|
| EBT Excluding Unusual Items | 14,241 | 13,117 | 10,860 | 8,850 | 7,316 | 5,401 | Upgrade
|
| Impairment of Goodwill | - | - | - | - | - | -94.47 | Upgrade
|
| Gain (Loss) on Sale of Investments | 164.47 | 69.56 | -26.44 | 9.88 | - | - | Upgrade
|
| Gain (Loss) on Sale of Assets | 6.12 | 2.46 | 6.16 | 4.07 | -2.07 | -1.49 | Upgrade
|
| Asset Writedown | -274.92 | -274.92 | -0.74 | -7.47 | -16.87 | -18.12 | Upgrade
|
| Legal Settlements | -18.5 | -12.65 | -3.3 | -5.7 | -2.45 | 2.41 | Upgrade
|
| Other Unusual Items | 124.62 | 109.68 | 117.5 | 166.78 | 143.74 | 78.52 | Upgrade
|
| Pretax Income | 14,243 | 13,011 | 10,954 | 9,017 | 7,438 | 5,368 | Upgrade
|
| Income Tax Expense | 1,532 | 1,433 | 1,343 | 1,013 | 778.84 | 683.44 | Upgrade
|
| Earnings From Continuing Operations | 12,711 | 11,578 | 9,611 | 8,004 | 6,660 | 4,685 | Upgrade
|
| Minority Interest in Earnings | -10.17 | 3.81 | -3.54 | -2.49 | -1.93 | -4.17 | Upgrade
|
| Net Income | 12,701 | 11,582 | 9,607 | 8,002 | 6,658 | 4,681 | Upgrade
|
| Net Income to Common | 12,701 | 11,582 | 9,607 | 8,002 | 6,658 | 4,681 | Upgrade
|
| Net Income Growth | 18.02% | 20.56% | 20.07% | 20.19% | 42.24% | 25.85% | Upgrade
|
| Shares Outstanding (Basic) | 1,211 | 1,212 | 1,210 | 1,215 | 1,216 | 1,216 | Upgrade
|
| Shares Outstanding (Diluted) | 1,212 | 1,212 | 1,210 | 1,215 | 1,216 | 1,216 | Upgrade
|
| Shares Change (YoY) | 0.04% | 0.11% | -0.36% | -0.07% | 0.00% | 9.17% | Upgrade
|
| EPS (Basic) | 10.48 | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | Upgrade
|
| EPS (Diluted) | 10.48 | 9.56 | 7.94 | 6.59 | 5.48 | 3.85 | Upgrade
|
| EPS Growth | 17.98% | 20.42% | 20.50% | 20.27% | 42.24% | 15.28% | Upgrade
|
| Free Cash Flow | 12,538 | 8,373 | 10,226 | 7,596 | 7,687 | 3,945 | Upgrade
|
| Free Cash Flow Per Share | 10.35 | 6.91 | 8.45 | 6.25 | 6.32 | 3.25 | Upgrade
|
| Dividend Per Share | 5.560 | 5.800 | 4.500 | 3.500 | 2.500 | 1.500 | Upgrade
|
| Dividend Growth | -36.82% | 28.89% | 28.57% | 40.00% | 66.67% | 50.00% | Upgrade
|
| Gross Margin | 65.77% | 65.43% | 63.92% | 64.51% | 64.52% | 64.97% | Upgrade
|
| Operating Margin | 36.72% | 35.10% | 34.28% | 34.68% | 34.52% | 30.16% | Upgrade
|
| Profit Margin | 34.34% | 33.16% | 31.64% | 31.66% | 31.66% | 28.27% | Upgrade
|
| Free Cash Flow Margin | 33.90% | 23.97% | 33.67% | 30.06% | 36.56% | 23.83% | Upgrade
|
| EBITDA | 14,595 | 13,126 | 11,188 | 9,380 | 7,731 | 5,388 | Upgrade
|
| EBITDA Margin | 39.46% | 37.58% | 36.84% | 37.12% | 36.77% | 32.54% | Upgrade
|
| D&A For EBITDA | 1,013 | 864.43 | 779.11 | 616.47 | 472.12 | 394.31 | Upgrade
|
| EBIT | 13,582 | 12,261 | 10,409 | 8,764 | 7,259 | 4,994 | Upgrade
|
| EBIT Margin | 36.72% | 35.10% | 34.28% | 34.68% | 34.52% | 30.16% | Upgrade
|
| Effective Tax Rate | 10.75% | 11.01% | 12.26% | 11.23% | 10.47% | 12.73% | Upgrade
|
| Revenue as Reported | 36,987 | 34,932 | 30,366 | 25,270 | - | 16,556 | Upgrade
|
| Advertising Expenses | - | 359.41 | 288.69 | 223.68 | 243.39 | 345.84 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.